Manuscript Questions Risk-to-Benefit Ratio of Covid Boosters

Written by Dr Peter McCullough MD, MPH on February 19, 2024. Posted in Current News

One of the most visible categories of immunocompromised patients we have in clinical practice are those who have undergone organ transplantation, most commonly kidney and heart.

A new analysis published suggests that continued boosters are weakening the immunity of those on immunosuppressives and thus allowing more not less COVID-19 infections.

Boretti, from the Melbourne Institute of Technology, makes these observations:

“A considerable body of evidence indicates a correlation, and some recent studies even suggest causation, highlighting the potential for mRNA COVID-19 boosters to have adverse effects on the immune system.

This is particularly relevant in the case of immunocompromised individuals, where the overall cost-to-benefit ratio may lean toward the negative.

A comprehensive, evidence-based assessment is essential to promptly evaluate the implications of continuous COVID-19 vaccine booster use for this specific population.

Given the decreased severity of the virus, as acknowledged in various jurisdictions, there are legitimate concerns about the frequent administration of boosters in immunocompromised patients, raising questions about whether this practice may be causing more harm than benefit.”

The manuscript does not address safety, however, as I point out in this recent vertical short video, injection of genetic code and then long-lasting expression of a foreign protein within tissues including the organ for or received for transplantation is a disastrous idea.

Simply put, COVID-19 genetic vaccination is an invitation for transplant organ failure.

Transplant programs that have been unbridled institutional zealots for novel genetic vaccination without long-term safety data or convincing randomized trial results on hard primary outcomes will have to come to grips with reality as more questions and poor results are returned.

See more here substack.com

Header image: Adobe Stock

Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.